Rainer Bredenkamp

1.2k total citations · 1 hit paper
13 papers, 848 citations indexed

About

Rainer Bredenkamp is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Rainer Bredenkamp has authored 13 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Rainer Bredenkamp's work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Esophageal Cancer Research and Treatment (4 papers). Rainer Bredenkamp is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Esophageal Cancer Research and Treatment (4 papers). Rainer Bredenkamp collaborates with scholars based in Germany and Austria. Rainer Bredenkamp's co-authors include Florian Lordick, Christian Peschel, Sylvie Lorenzen, Markus Schwaiger, Ken Herrmann, Wolfgang Weber, Hinrich Wieder, Katja Ott, Karen Becker and H. J. Stein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Rainer Bredenkamp

12 papers receiving 831 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

2007 550 citations Florian Lordick, Katja Ott et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Rainer Bredenkamp

Since Specialization

Citations

This map shows the geographic impact of Rainer Bredenkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Bredenkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Bredenkamp more than expected).

Fields of papers citing papers by Rainer Bredenkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Bredenkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Bredenkamp. The network helps show where Rainer Bredenkamp may publish in the future.

Co-authorship network of co-authors of Rainer Bredenkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Bredenkamp. A scholar is included among the top collaborators of Rainer Bredenkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Bredenkamp. Rainer Bredenkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Health Effects of a 12-Week Web-Based Lifestyle Intervention for Physically Inactive and Overweight or Obese Adults: Study Protocol of Two Randomized Controlled Clinical Trials 2022 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), (unknown), Reinhard Fuchs, (unknown), (unknown), (unknown), (unknown), (unknown), Erik Farin‐Glattacker, (unknown), Rainer Bredenkamp, Albert Gollhofer, Daniel König	9
2	Effectiveness of an interactive web-based health program for adults: a study protocol for three concurrent controlled-randomized trials (EVA-TK-Coach) 2021 ·Trials ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel König, (unknown), Reinhard Fuchs, (unknown), Rainer Bredenkamp, Erik Farin‐Glattacker	8
3	Evaluation of a Mobile Phone App for Patients With Pollen-Related Allergic Rhinitis: Prospective Longitudinal Field Study 2020 ·JMIR mhealth and uhealth ·Manuela Glattacker, Martin Boeker, (unknown), Frank Reichenbach, Adrian Tassoni, Rainer Bredenkamp, (unknown)	15
4	First Results of the Interdisciplinary Comprehensive Cancer Center Freiburg (CCCF) Tumor Board (TB) Multiple Myeloma (MM) Assessing TB-Questions, TB-Advice Adherence, TB-Satisfaction of Patients, Participants and Referring Physicians, Inclusion of Difficult-to-Treat-MM Pts in Clinical Trials (CT) and Patient Outcome 2014 ·Blood ·(unknown), (unknown), (unknown), Johannes M. Waldschmidt, Milena Pantić, Georg W. Herget, Karl Henne, Annette M. May, Martina Kleber, (unknown), Gabriele Ihorst, Rainer Bredenkamp, Werner Vach, Justus Duyster, Ralph Wäsch, Monika Engelhardt	2
5	Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET 2007 ·Nuklearmedizin - NuclearMedicine ·Sylvie Lorenzen, Ken Herrmann, Wolfgang Weber, Hinrich Wieder, Michael Hennig, (unknown), Rainer Bredenkamp, C. Peschel, Markus Schwaiger, Florian Lordick	5
6	PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial breakdown → 2007 ·The Lancet Oncology ·Florian Lordick, Katja Ott, Bernd‐Joachim Krause, Wolfgang Weber, Karen Becker, H. J. Stein, Sylvie Lorenzen, Tibor Schuster, Hinrich Wieder, Ken Herrmann, Rainer Bredenkamp, Heinz Höfler, U. Fink, Christian Peschel, Markus Schwaiger, J. R. Siewert	550
7	Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study 2006 ·Investigational New Drugs ·Stefan von Delius, Florian Eckel, Stefan Wagenpfeil, Martina Mayr, Konrad Stock, Frank Kullmann, Florian Obermeier, Johannes Erdmann, Renate Schmelz, Stefan Quasthoff, Helmuth Adelsberger, Rainer Bredenkamp, Roland M. Schmid, C. Lersch	77
8	Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial 2005 ·British Journal of Cancer ·Sylvie Lorenzen, Justus Duyster, C. Lersch, Stefan von Delius, Michael Hennig, Rainer Bredenkamp, Christian Peschel, Florian Lordick	45
9	Oxaliplatin plus 5FU/folinic acid (FUFOX Regimen) in 1^st line metastatic gastric cancer (MGC). Results of the Multicenter Phase II STOMOX Trial 2005 ·Journal of Clinical Oncology ·Justus Duyster, Sylvie Lorenzen, Frank Kullmann, M. Hentrich, (unknown), (unknown), (unknown), Rainer Bredenkamp, C. Peschel, Florian Lordick	3
10	Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer 2005 ·British Journal of Cancer ·Florian Lordick, Sylvie Lorenzen, J. Stollfuß, Ursula Vehling‐Kaiser, Frank Kullmann, Marcus Hentrich, (unknown), (unknown), (unknown), Michael Hennig, (unknown), Rainer Bredenkamp, Justus Duyster, C. Peschel	69
11	Three-weekly docetaxel (T) plus capecitabine (X) in 1^st and 2^nd line metastatic esophageal cancer (MEC): Final Results of the phase II DACAPO Trial 2005 ·Journal of Clinical Oncology ·Sylvie Lorenzen, Justus Duyster, C. Lersch, Stefan von Delius, Brian Hung‐Hin Lang, Michael Hennig, Rainer Bredenkamp, C. Peschel, Florian Lordick	7
12	Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer 2003 ·British Journal of Cancer ·Florian Lordick, C. von Schilling, H. Bernhard, Michael Hennig, Rainer Bredenkamp, Christian Peschel	57
13	Erarbeitung und Verbreitung von Standards in der Onkologie 1998 ·Der Onkologe ·(unknown), Rainer Bredenkamp	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact